• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[采用EQ-5D和SF-6D测量的中风患者的健康效用值]

[Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D].

作者信息

Du Xu-Dong, Zhu Ping, Li Mi-Er, Wang Ju, Meng Hong-Dao, Zhu Cai-Rong

机构信息

Department of Epidemiology and Health Statistics,West China School of Public Health,Sichuan University,Chengdu 610041,China.

University of South Florida,College of Behavioral & Community Sciences,School of Aging Studies, Tampa 33620,United States.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Mar;49(2):252-257.

PMID:29737071
Abstract

OBJECTIVE

To compare EQ-5D and SF-6D for measuring health utility of stroke patients in health economic evaluation studies.

METHODS

A prospective cohort study was conducted on 596 stroke patients in the West China Hospital of Sichuan University from 2010 to 2016. Data were collected at baseline through face to face interviews and at the follow-up stages through telephone interviews with a three-month interval. EQ-5D and SF-6D were used for measuring health utility scores of the participants. The consistency of the two instruments was assessed using Bland-Altman plot and Intraclass correlation coefficient () . Logistic regression models were established to identify predictors of health utility.

RESULTS

The participants had a mean utility score of 0.78 (95% confidence interval:0.76, 0.80) in EQ-5D,compared with 0.74 (95% confidence interval: 0.73, 0.76) in SF-6D,and a median (interquartile range) of 0.86 (0.68, 1.00) in EQ-5D and 0.73 (0.62, 0.86) in SF-6D. The 95% limits of agreement between the two instruments ranged from -0.28 to 0.35,with an of 0.67 (95% confidence interval: 0.62,0.71). EQ-5D had a higher ceiling effect. The health utility score of stroke patients changed there rapidly in acute phase (less than 3 months) but barely changed there after.Severity of stroke was a major predictor of health utility scores.

CONCLUSION

The two instruments generate inconsistent results in health utility. SF-6D is better for measuring health utility in patients with stroke in China.

摘要

目的

在健康经济评估研究中比较EQ-5D和SF-6D用于测量中风患者的健康效用。

方法

对2010年至2016年四川大学华西医院的596例中风患者进行了一项前瞻性队列研究。在基线时通过面对面访谈收集数据,在随访阶段通过每隔三个月的电话访谈收集数据。使用EQ-5D和SF-6D测量参与者的健康效用得分。使用Bland-Altman图和组内相关系数评估这两种工具的一致性。建立逻辑回归模型以确定健康效用的预测因素。

结果

EQ-5D中参与者的平均效用得分为0.78(95%置信区间:0.76,0.80),而SF-6D中为0.74(95%置信区间:0.73,0.76),EQ-5D的中位数(四分位间距)为0.86(0.68,1.00),SF-6D为0.73(0.62,0.86)。两种工具之间的95%一致性界限为-0.28至0.35,组内相关系数为0.67(95%置信区间:0.62,0.71)。EQ-5D有更高的天花板效应。中风患者的健康效用得分在急性期(少于3个月)变化迅速,但之后几乎没有变化。中风严重程度是健康效用得分的主要预测因素

结论

这两种工具在健康效用方面产生不一致的结果。在中国SF-6D更适合测量中风患者的健康效用。

相似文献

1
[Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D].[采用EQ-5D和SF-6D测量的中风患者的健康效用值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Mar;49(2):252-257.
2
A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.类风湿关节炎患者使用 EQ-5D 和 SF-6D 偏好型通用量表进行效用测量的比较。
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.
3
Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.慢性前列腺炎患者的 EuroQol 和简短形式 6D 的验证和比较。
Value Health. 2010 Aug;13(5):649-56. doi: 10.1111/j.1524-4733.2010.00728.x. Epub 2010 Apr 15.
4
Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.泰国腹膜透析患者中EQ-5D-5L、视觉模拟评分法(VAS)和SF-6D的比较
Value Health Reg Issues. 2019 May;18:59-64. doi: 10.1016/j.vhri.2018.08.005. Epub 2018 Nov 28.
5
Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.新加坡计划进行全膝关节置换术的多民族亚洲膝骨关节炎患者中欧洲五维健康量表与简版6D量表的比较
Arthritis Rheum. 2007 Aug 15;57(6):1043-9. doi: 10.1002/art.22883.
6
Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.稳定型心绞痛患者中欧洲五维度健康量表(EQ - 5D)与简短健康调查简表6维度(SF - 6D)的验证与比较
Health Qual Life Outcomes. 2014 Oct 25;12:156. doi: 10.1186/s12955-014-0156-6.
7
A comparison of four different approaches to measuring health utility in depressed patients.四种不同方法在抑郁患者中测量健康效用的比较。
Health Qual Life Outcomes. 2013 May 9;11:81. doi: 10.1186/1477-7525-11-81.
8
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.骨折联络服务就诊的荷兰骨折患者中 EQ-5D-5L 与 SF-6D 的头对头比较。
J Med Econ. 2022 Jan-Dec;25(1):829-839. doi: 10.1080/13696998.2022.2087409.
9
EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.脊髓延髓肌肉萎缩症患者的EQ-5D和SF-6D健康效用评分
Eur J Health Econ. 2023 Nov;24(8):1399-1410. doi: 10.1007/s10198-022-01551-w. Epub 2022 Nov 23.
10
Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.813 例早期关节炎患者的 EQ-5D 和 SF-6D 效用测量比较:来自 ESPOIR 队列的结果。
J Rheumatol. 2011 Aug;38(8):1576-84. doi: 10.3899/jrheum.101006. Epub 2011 May 1.

引用本文的文献

1
Cost-effectiveness analysis of duodenal-jejunal bypass sleeve device for people with obesity.十二指肠空肠旁路套筒装置用于肥胖人群的成本效益分析。
Health Econ Rev. 2025 Apr 8;15(1):32. doi: 10.1186/s13561-025-00623-w.
2
Assessing health-related quality of life of Chinese population using CQ-11D.使用 CQ-11D 评估中国人群的健康相关生命质量。
Health Qual Life Outcomes. 2024 Apr 19;22(1):34. doi: 10.1186/s12955-024-02250-1.
3
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China.
中国急性心肌梗死患者使用依洛尤单抗降低低密度脂蛋白胆固醇(LDL-C)的成本效益分析方法及结果
Cost Eff Resour Alloc. 2023 Dec 1;21(1):93. doi: 10.1186/s12962-023-00501-4.
4
A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population.基于中国人群的中医健康状况量表(CQ-11D)与 EQ-5D-5L 和 SF-6D 量表的对比研究。
Qual Life Res. 2024 Jan;33(1):113-122. doi: 10.1007/s11136-023-03512-z. Epub 2023 Sep 11.
5
Health utility in community-dwelling adults with dysvascular lower limb loss.社区居住的下肢血管性缺失成年人的健康效用。
Qual Life Res. 2023 Jul;32(7):1871-1881. doi: 10.1007/s11136-023-03357-6. Epub 2023 Feb 9.
6
Patent foramen ovale closure vs. medical therapy alone after cryptogenic stroke in China: A cost-effectiveness analysis.卵圆孔未闭封堵术与单独药物治疗中国不明原因卒中:成本效果分析。
Front Public Health. 2022 Nov 3;10:1016854. doi: 10.3389/fpubh.2022.1016854. eCollection 2022.
7
Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension.叶酸治疗高血压患者预防中风的成本效益。
BMC Med. 2022 Oct 25;20(1):407. doi: 10.1186/s12916-022-02601-z.
8
Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.脑卒中患者的健康状态效用值:系统评价和荟萃分析。
J Am Heart Assoc. 2022 Jul 5;11(13):e024296. doi: 10.1161/JAHA.121.024296. Epub 2022 Jun 22.
9
Time to recurrence after first-ever ischaemic stroke within 3 years and its risk factors in Chinese population: a prospective cohort study.首次缺血性脑卒中后 3 年内复发时间及其中国人群的危险因素:一项前瞻性队列研究。
BMJ Open. 2019 Dec 18;9(12):e032087. doi: 10.1136/bmjopen-2019-032087.
10
Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.使用真实世界数据比较灵活参数生存模型和 Cox 模型估计马尔可夫转移概率。
PLoS One. 2018 Aug 22;13(8):e0200807. doi: 10.1371/journal.pone.0200807. eCollection 2018.